Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Tirzepatide Updates

Diana Isaacs

Weightloss in Menopause

Susan Brian

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Michigan Medicine - Podiatry

G. Rothenberg

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann